Attenuated rubella vaccine (HPV-77): evaluation in a large controlled trial.
D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005260:Female; D005334:Fever / Q000139:chemically induced; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D010919:Placebos; D012409:Rubella / Q000276:immunology*; D012411:Rubella Vaccine / Q000009:adverse effects; D012412:Rubella virus; D014611:Vaccination / Q000009:adverse effects; D014765:Viral Vaccines
D000906:Antibodies; D010919:Placebos; D012411:Rubella Vaccine; D014765:Viral Vaccines